首页> 美国卫生研究院文献>Oncology Reports >Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion
【2h】

Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion

机译:TRIM58表达的下调与患者预后不良相关并增强了结直肠癌细胞的侵袭能力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

TRIM58 is a member of the tripartite motif protein (TRIM) family of E3 ubiquitin ligases. Aberrant gene methylation of TRIM58 has been reported in liver and lung cancer and indicates a poor patient prognosis. However, the expression level and functional role of TRIM58 in colorectal cancer (CRC) have yet to be elucidated. In the present study, we found that TRIM58 expression was significantly suppressed in human CRC and was inversely correlated with CRC progression. Additionally, overall survival was significantly reduced in patients with low TRIM58 expression in CRC tumors. In vitro studies demonstrated that ectopic TRIM58 overexpression strongly inhibited CRC cell invasion but had minimal effects on cell proliferation, colonization and migration. Furthermore, TRIM58 suppression enhanced the expression of epithelial-to-mesenchymal transition (EMT) and matrix metalloproteinase (MMP) genes. Thus, our findings suggest that TRIM58 is a potential prognostic marker of CRC and functions as a tumor-suppressor gene via inhibition of cancer cell invasion through EMT and MMP activation.
机译:TRIM58是E3泛素连接酶的三重基序蛋白(TRIM)家族的成员。在肝癌和肺癌中已经报道了TRIM58的异常基因甲基化,表明患者预后不良。但是,TRIM58在结直肠癌(CRC)中的表达水平和功能作用尚待阐明。在本研究中,我们发现TRIM58表达在人CRC中被显着抑制,并且与CRC进展呈负相关。另外,在CRC肿瘤中具有低TRIM58表达的患者的总生存期显着降低。体外研究表明,异位TRIM58过表达强烈抑制CRC细胞侵袭,但对细胞增殖,定植和迁移影响最小。此外,TRIM58抑制增强了上皮到间质转化(EMT)和基质金属蛋白酶(MMP)基因的表达。因此,我们的研究结果表明,TRIM58是CRC的潜在预后标志物,并通过抑制癌细胞通过EMT和MMP激活而成为肿瘤抑制基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号